Leaders of research and programmatic responses to HIV globally gathered on Capitol Hill Thursday to celebrate the 15th anniversary of the President’s Emergency Plan for AIDS Relief launch and the flagship program’s achievements, but also to cite urgent needs to strengthen and accelerate the program’s efforts toward ending the pandemic.
The U.S. Senate voted overwhelmingly last night to approve the Opioids Crisis Response Act of 2018 – their version of the comprehensive legislation (HR 6) passed by the U.S. House of Representatives in June. The Infectious Diseases Society of America, the HIV Medicine Association, and the Pediatric Infectious Diseases Society support the bill as an important step to improve access to substance use treatment and to responding to the significant rise in infectious diseases associated with injection drug use
The Labor, Health, and Human Services, and Defense Department Senate and House conference agreement released Thursday demonstrates legislators’ commitment to tackling some of the most critical health issues our nation faces. The agreement includes a $263 million increase in funding for the National Institute of Allergy and Infectious Diseases supporting essential biomedical research and development, and $5 million added to 2018 funding levels for HIV, hepatitis, sexually transmitted diseases and tuberculosis prevention at the Centers for Disease Control and Prevention. While the increase reflected in the $1.132 billion allotted to CDC’s National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, keeps funding for the four main divisions at 2018 levels, it also includes an allotment for a new center-wide initiative to prioritize areas most at risk for outbreaks of HIV and hepatitis due to injection drug use and the opioid epidemic, an important step in combating an ongoing crisis.
As the hurricane season reaches its peak, and Hurricane Florence brings threats of catastrophic weather events and flooding to the eastern United States, preparation and sustained responses will be essential to prevent and respond to public health and infectious disease impacts that pose risks in a storm’s aftermath.
While diagnostic tools and medicines can easily detect and treat sexually transmitted diseases, the Centers for Disease Control and Prevention reported in late August a record high of 2.3 million new cases of chlamydia, gonorrhea and syphilis in the U.S. 2017. The news represented the fourth consecutive year of significant increases in diagnoses and highlight needs for urgent, focused, and evidenced based policies and funding commitments.
As thousands of physicians, including those providing infectious diseases and HIV care, cited damaging impacts of a Centers for Medicare & Medicaid Services proposal to slash reimbursements for evaluation and management of complex cases, lawmakers are signing onto a letter asking the agency to delay action on the move.
Today the National Academies of Science, Engineering and Medicine released Integrating Responses at the Intersection of Opioid Use Disorder and Infectious Disease Epidemics, a report documenting the proceedings of a two-day meeting of public health, drug policy and law enforcement experts, including leaders of the Infectious Diseases Society of America and the HIV Medicine Association.
Senate appropriators last Friday released a bill for the coming year that repudiates both White House proposals for draconian cuts to essential public health and research programs, and a House proposal to eliminate critically needed family planning programs, important steps in addressing the unprecedented and evolving health threats we will face in 2019.
The spending bill released Friday by the Senate Appropriations State and Foreign Operations subcommittee, proposing the first increase in funding for the U.S. President’s Emergency Plan for AIDS Relief in nearly a decade, and the robust increase proposed by the House Appropriations State and Foreign Operations subcommittee for USAID’s global efforts to combat tuberculosis, demonstrate a welcome awareness of the tremendous value of continued U.S. leadership of crucial global health responses.
HIVMA and the IDSA Foundation are pleased to announce the selection of 15 medical students from across the US who will receive funding for clinical learning and research projects through the HIVMA Medical Students Program.